NO970902L - Ikke selvinaktiverende, målrettet retroviral ekspresjonsvektorer - Google Patents

Ikke selvinaktiverende, målrettet retroviral ekspresjonsvektorer

Info

Publication number
NO970902L
NO970902L NO970902A NO970902A NO970902L NO 970902 L NO970902 L NO 970902L NO 970902 A NO970902 A NO 970902A NO 970902 A NO970902 A NO 970902A NO 970902 L NO970902 L NO 970902L
Authority
NO
Norway
Prior art keywords
region
inactivating
expression vectors
retroviral expression
targeted retroviral
Prior art date
Application number
NO970902A
Other languages
English (en)
Other versions
NO970902D0 (no
NO317731B1 (no
Inventor
Walter Henry Guenzburg
Robert Michael Saller
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Publication of NO970902D0 publication Critical patent/NO970902D0/no
Publication of NO970902L publication Critical patent/NO970902L/no
Publication of NO317731B1 publication Critical patent/NO317731B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Road Signs Or Road Markings (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO19970902A 1994-09-02 1997-02-27 Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer NO317731B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (3)

Publication Number Publication Date
NO970902D0 NO970902D0 (no) 1997-02-27
NO970902L true NO970902L (no) 1997-04-24
NO317731B1 NO317731B1 (no) 2004-12-13

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970902A NO317731B1 (no) 1994-09-02 1997-02-27 Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer

Country Status (21)

Country Link
US (1) US7531353B1 (no)
EP (1) EP0779929B1 (no)
JP (1) JP4037446B2 (no)
CN (1) CN1117156C (no)
AT (1) ATE200517T1 (no)
AU (1) AU688590B2 (no)
BR (1) BR9508664A (no)
CA (1) CA2198210C (no)
DE (1) DE69520681T2 (no)
DK (1) DK0779929T5 (no)
EE (1) EE03492B1 (no)
ES (1) ES2156945T3 (no)
FI (1) FI970892A (no)
HK (1) HK1001527A1 (no)
HU (1) HU221607B (no)
MX (1) MX9701544A (no)
NO (1) NO317731B1 (no)
NZ (1) NZ292897A (no)
PL (1) PL184375B1 (no)
RU (1) RU2199585C2 (no)
WO (1) WO1996007748A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688590B2 (en) 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
EP0817858B1 (en) * 1995-03-09 2003-04-23 Austrian Nordic Biotherapeutics AG Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
CN1187095C (zh) 1995-06-27 2005-02-02 巴法里安诺迪克有限公司 可生产病毒颗粒的被囊化细胞
ES2176500T3 (es) * 1995-10-13 2002-12-01 Austrian Nordic Biotherapeutic Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1.
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
SI0892852T1 (sl) 1996-03-27 2006-04-30 Bavarian Nordic As Inkapsulirane celice, ki eksprimirajo citokrom P450 za aktiviranje predzdravila
WO1998032869A1 (en) * 1997-01-29 1998-07-30 Neurosearch A/S Expression vectors and methods for in vivo expression of therapeutic polypeptides
CN1322137C (zh) * 1997-12-22 2007-06-20 牛津生物医学（英国）有限公司 基于马传染性贫血病毒(eiav)的逆转录病毒载体
EP1045922B1 (en) 1998-01-06 2004-09-29 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Reconstituting retroviral vector (recon vector) for targeted gene expression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
EP1173597A1 (en) * 1999-04-29 2002-01-23 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE142268T1 (de) 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer Retroviraler vektor
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
AU688590B2 (en) 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
ATE212061T1 (de) * 1995-03-09 2002-02-15 Austrian Nordic Biotherapeutic Rekombinante dna-vektoren für die gentherapie
EP0817858B1 (en) * 1995-03-09 2003-04-23 Austrian Nordic Biotherapeutics AG Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
CA2198210A1 (en) 1996-03-14
JP4037446B2 (ja) 2008-01-23
PL184375B1 (pl) 2002-10-31
MX9701544A (es) 1998-03-31
DK0779929T5 (da) 2001-08-13
DK0779929T3 (da) 2001-05-07
NO970902D0 (no) 1997-02-27
BR9508664A (pt) 1998-01-06
DE69520681T2 (de) 2001-11-29
EP0779929B1 (en) 2001-04-11
WO1996007748A1 (en) 1996-03-14
ES2156945T3 (es) 2001-08-01
NO317731B1 (no) 2004-12-13
AU688590B2 (en) 1998-03-12
FI970892A0 (fi) 1997-02-28
NZ292897A (en) 1998-08-26
RU2199585C2 (ru) 2003-02-27
CN1117156C (zh) 2003-08-06
DE69520681D1 (de) 2001-05-17
AU3520195A (en) 1996-03-27
HK1001527A1 (en) 1998-06-26
CA2198210C (en) 2006-07-11
EE9700040A (et) 1997-08-15
FI970892A (fi) 1997-02-28
JPH10507628A (ja) 1998-07-28
HUT76974A (hu) 1998-01-28
HU221607B (hu) 2002-11-28
PL319033A1 (en) 1997-07-21
ATE200517T1 (de) 2001-04-15
CN1159210A (zh) 1997-09-10
US7531353B1 (en) 2009-05-12
EE03492B1 (et) 2001-08-15
EP0779929A1 (en) 1997-06-25

Similar Documents

Publication Publication Date Title
NO970902L (no) Ikke selvinaktiverende, målrettet retroviral ekspresjonsvektorer
ATE179895T1 (de) Wundabdeckungsmaterial auf basis von kollagenfasern
WO1998039463A3 (en) Lentivirus based vector and vector system
AUPO787897A0 (en) Silicon-containing chain extenders
TR199802695T2 (xx) IL-8 Resept�r kar��tlar�
DE69822117D1 (de) Verfahren zur Herstellung von olefinischen Epoxiden
EP0624680A4 (en) TREATMENT FOR FIBER PRODUCTS, METHOD FOR TREATING FIBER PRODUCTS, AND THE FIBER PRODUCTS TREATED BY THIS.
DE69520356D1 (de) Herstellung von pentafluoroethane
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2139888T3 (es) Composicion acondicionadora del cabello.
DE69624007D1 (de) Haarformungsmittel
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
CA2267945A1 (en) Anticonvulsant derivatives useful in treating neuropathic pain
DE59109072D1 (de) Klonierung der N-Methylhydantoinase
MX9605731A (es) Preparacion de un catalizador de hidratacion con empleo de m(or)mxn.
DE69810530D1 (de) Ethylenpolymerisationsverfahren in Gegenwart eines Chromoxydkatalysators
DE3688383D1 (de) Rekombinantes vektorsystem fuer metalloproteinase-inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
MX9707249A (es) Catalizador y proceso para la hidrogenacion de olefinas o polimeros.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees